10 completed, 3 withdrawn, 1 recruiting, 1 unknown. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Completed 10, Withdrawn 3, Recruiting 1, Unknown 1 |
Follow Alcohol Drinking: new trials by email Literature Review of Alcohol Drinking trials Research Report on Alcohol Drinking
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Research on Translational Outcomes of Alcohol (Project RETRO) Carbidopa Levodopa, Placebo - Alcohol Drinking | Phase 4 | Withdrawn | University of Washington | 2023-02-01 | 2023-02-13 | |
| Effects of THC and Alcohol on Driving Performance THC 0, THC 5, THC 10 - Cannabis, Alcohol Drinking | Phase 4 | Withdrawn | Lakehead University | 2021-07-01 | 2022-04-25 | |
| ANCHORS Alcohol & Sexual Health Study: UH3 Project PrEP acronym (pre-exposure prophylaxis), Initial Web Survey, Interactive Voice Response (IVR) monitoring - Alcohol Use, Unspecified, Substance Use | Phase 4 | Recruiting | University of Florida | 88 | 2021-01-12 | 2025-07-10 |
| Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation Chantix, Behavioral Counseling Sessions, NicodermCQ - Smoking Cessation, Alcohol Drinking | Phase 4 | Completed | University of Chicago | 122 | 2018-03-29 | 2021-09-27 |
| Alcohol Research Consortium in HIV-Intervention Research Arm Computerized Brief Intervention (CBI), CBT4CBT, Recommendation and Counseling for Alcohol Pharmacotherapy - HIV Positive, Alcohol Use | Phase 4 | Completed | University of Alabama at Birmingham | 4985 | 2017-11-06 | 2025-03-10 |
| Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking Nicotine Replacement Therapy, Bupropion, Cognitive Behavioral Treatment - Smoking Cessation, Alcohol Drinking | Phase 4 | Completed | Duke University | 45 | 2016-11-01 | 2021-04-28 |
| Effects of Varenicline in Heavy Drinking Smokers Varenicline, Placebo pill (for varenicline), Alcohol - Cigarette Smoking, Alcohol Consumption | Phase 4 | Withdrawn | University of California, Los Angeles | 2015-08-01 | 2018-06-01 | |
| Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use nalmefene - Alcohol Dependence | Phase 4 | Completed | H. Lundbeck A/S | 45 | 2014-09-01 | 2016-12-14 |
| Paradoxical Excitement Response During Sedation Between Dexmedetomidine and Propofol in Hazardous Alcohol Drinker Dexmedetomidine, Propofol - Anesthesia, Spinal, Sedation, Conscious | Phase 4 | Unknown | Chonnam National University Hospital | 110 | 2013-12-01 | 2019-03-14 |
| Strong African American Families STEPS Project Strong African American Families Program, Strong African American Families--Teen Program - Adolescent Alcohol Use | Phase 4 | Completed | University of Georgia | 472 | 2012-12-10 | 2019-06-19 |
| Naltrexone for Heavy Drinking in Young Adults BASICS counseling, naltrexone, placebo naltrexone - Alcohol Consumption, Alcoholic Intoxication | Phase 4 | Completed | Yale University | 140 | 2008-02-01 | 2020-03-30 |
| Topiramate Treatment of Problem Drinkers topiramate, placebo - Alcohol Drinking | Phase 4 | Completed | UConn Health | 200 | 2008-02-01 | 2018-03-08 |
| Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders Vivitrol (Medication Therapy), Medication Management Therapy - Alcohol Consumption | Phase 4 | Completed | Pacific Institute for Research and Evaluation | 14 | 2007-04-01 | 2012-08-27 |
| Sertraline Pharmacotherapy for Alcoholism Subtypes Sertraline, Placebo - Alcoholism | Phase 4 | Completed | UConn Health | 134 | 2004-02-01 | 2011-06-21 |
| Targeted Naltrexone for Problem Drinkers Naltrexone, placebo - Alcoholism, Alcohol Drinking | Phase 4 | Completed | UConn Health | 163 | 2003-06-01 | 2011-06-20 |
Alcoholism (4) · Smoking Cessation (2) · Alcohol-Induced Disorders (1) · Alcoholic Intoxication (1) · Cigarette Smoking (1) · HIV Seropositivity (1) · Marijuana Abuse (1) · Sexual Behavior (1) · Substance-Related Disorders (1) · Underage Drinking (1)
Behavior (15) · Drinking Behavior (15) · Chemically-Induced Disorders (6) · Mental Disorders (6) · Substance-Related Disorders (5) · Alcohol-Related Disorders (4) · Health Behavior (2) · Adolescent Behavior (1) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · HIV Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1)
Ethanol (3) · Naltrexone (2) · Varenicline (2) · APT (1) · Bupropion (1) · Cognitive Behavioral Therapy (1) · Counseling (1) · Crisis Intervention (1) · Dexmedetomidine (1) · Dronabinol (1) · Drug Therapy (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Medication Therapy Management (1) · Nebulizers and Vaporizers (1) · Nicotine Chewing Gum (1)
UConn Health (3) · Chonnam National University Hospital (1) · Duke University (1) · H. Lundbeck A/S (1) · Lakehead University (1) · Pacific Institute for Research and Evaluation (1) · University of Alabama at Birmingham (1) · University of California, Los Angeles (1) · University of Chicago (1) · University of Florida (1) · University of Georgia (1) · University of Washington (1) · Yale University (1)
United States (10) · Germany (1) · South Korea (1)
Henry R. Kranzler, MD (2) · Andrea King, Ph.D. (1) · Brittney Hultgren, PhD (1) · Eric A. Dedert, Ph.D. (1) · Henry R Kranzler, M.D. (1) · Hyunjung Lee, MD, Master (1) · Jeongil Choi, MD, PhD (1) · Robert L. Cook, PhD (1) · Sandra Lapham, MD, MPH (1) · Stephanie O'Malley, PhD (1)
PMID 19593174, PMID 19713256, PMID 21903640, PMID 21981418, PMID 22436955, PMID 23145795, PMID 23748199, PMID 24786948, PMID 25742208, PMID 26891181, PMID 34049101, PMID 34611902, PMID 35229945, PMID 35244704, PMID 37910105, PMID 39868569, PMID 40445294, PMID 40676489
2014 (1), F31AA028751 (1), M01RR006192 (1), P60AA003510 (1), R01AA013631 (1), R01AA016621 (1), UH3AA026214 (1)